Friedman Ashley 4
4 · TELA Bio, Inc. · Filed Nov 13, 2019
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Friedman Ashley
Director
Transactions
- Conversion
Warrant (right to buy)
2019-11-13+31,168→ 31,168 total(indirect: By Partnership)Exercise: $28.65From: 2019-11-13Exp: 2027-01-18→ Common Stock (1,262 underlying) - Conversion
Warrant (right to buy)
2019-11-13+148,499→ 148,499 total(indirect: By Partnership)Exercise: $28.65From: 2019-11-13Exp: 2027-01-18→ Common Stock (6,014 underlying) - Conversion
Series B Preferred Stock
2019-11-13−7,051,009→ 0 total(indirect: By Partnership)→ Common Stock (285,580 underlying) - Conversion
Common Stock
2019-11-13+59,940→ 106,052 total(indirect: By Partnership) - Conversion
Common Stock
2019-11-13+285,580→ 505,281 total(indirect: By Partnership) - Conversion
Warrant (right to buy)
2019-11-13−31,168→ 0 total(indirect: By Partnership)Exercise: $1.16From: 2017-01-18Exp: 2027-01-18→ Series B Preferred Stock (31,168 underlying) - Conversion
Series B Preferred Stock
2019-11-13−1,479,951→ 0 total(indirect: By Partnership)→ Common Stock (59,940 underlying) - Conversion
Warrant (right to buy)
2019-11-13−148,499→ 0 total(indirect: By Partnership)Exercise: $1.16From: 2017-01-18Exp: 2027-01-18→ Series B Preferred Stock (148,499 underlying)
Footnotes (5)
- [F1]Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
- [F2]Reflects 46,112 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
- [F3]Reflects 219,701 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
- [F4]Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.
- [F5]Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.